Vnitr Lek 2006, 52(7-8):726-729

Early diagnostics of ankylosing spondylitis

K. Pavelka
Revmatologický ústav, Praha, ředitel prof. MUDr. Karel Pavelka, DrSc.

The present study surveys the problems of diagnostics of early ankylosing spondylitis (AS) and axial spondylarthritis (SpA). Epidemiologic studies repeatedly identified seven- to nine-year delay of diagnosis of AS from its development to its first manifestations. Delayed diagnostics is caused both by unfamiliarity of rheumatologists with the disease and the inappropriateness of New York classification criteria for early stages of AS. In this study, we suggest diagnostic algorithms allowing high probability diagnosis of AS/axial in X-ray silent stage (the so-called pre X-ray stage). Spondylarthritis represents approximately 5 % of a total number of chronic low back pain (CLBP) cases. The probability grows up to 15% with the presence of inflammatory character of back pain. The presence of HLA B 27 increases the probability to 59 % and the occurrence of other 1 or 2 clinical signs raises the probability up to 90 %. Probability reaches 95% with positive MRI. The overall concept requires verification of new samples in a prospective study. After certification of such study, it will be possible to use biological medications for much more efficient therapy of patients in early AS stages.

Keywords: ankylosing spondylitis; spondylarthritis; biological therapy

Received: March 6, 2006; Published: July 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavelka K. Early diagnostics of ankylosing spondylitis. Vnitr Lek. 2006;52(7-8):726-729.
Download citation

References

  1. Braun J, Bollow M, Remlinger G et al. Prevalence of spondylarthropathies in HLA B 27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67. Go to original source...
  2. Saraux A, Gaudes G, Allain J et al. Prevalence of rheumatoid arthritis and spondylarthropathy in Britany, France. J Rheumatol 1999; 26: 2622-2627. Go to PubMed...
  3. Hánová P, Pavelka K, Dostál C et al. Epidemiology of rheumatoid arthritis, and gout in two regions of the Czech Republic in population-based survey in 2002-2003. Clin Exp Rheum 2006 (v tisku).
  4. Sieper J, Braun J, Rudwalent M et al. Ankylosing spondylitis an overview. Ann Rheum Dis 2002; 61(Suppl 3): ii8-ii18. Go to original source... Go to PubMed...
  5. Pavelka K, Štolfa J, Forejtová Š et al. Which factors influence quality of life of patients with ankylosing spondylitis. 6th Central European Congress of Rheumatology, 5.-7. 5. 2006, Bled, Slovinsko (abstrakt).
  6. Rudwailet M, Khan MA, Sieper J The challenge of diagnosis and classification in early ankylosing spondylitis. Do we need new criteria? Arthritis Rheum 2005; 52: 1000-1008. Go to original source... Go to PubMed...
  7. Kellgren JH, Jeffrey MR, Ball J. The epidemiology of chronic rheumatism. Oxford: Blackwell Scientific Publications 1963: vol. 1, 326-327.
  8. Gofton JP, Lawrence JS, Bennett PH et al. Sacroiliitis in eight populations. Ann Rheum Dis 1966; 25: 528-533. Go to original source... Go to PubMed...
  9. Bennett PH, Wood PH. Population studies of the rheumatic diseases. Amsterdam: Excerpta Medica Foundation 1968: 456-457.
  10. Van der Linden SM, Valkenburg HA, Cats A. Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27(4): 361-368. Go to original source... Go to PubMed...
  11. Mau W, Zeidler H, Mau R et al. Clinical features and prognosis of patients with possible ankylosing spondylitis: results of a 10-year followup. J Rheumatol 1988; 15: 11069-11074.
  12. Oostveen J, Prevo R, den Boer J et al. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography: a prospective, longitudinal study. J Rheumatol 1999; 26: 1953-1958. Go to PubMed...
  13. Braun J, Bollow M, Eggens U et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994; 37: 1039-1045. Go to original source... Go to PubMed...
  14. Rudwaleit M, van der Heide D, Khan MA et al. How to diagnose axial spondylarthropathies early. Ann Rheum Dis 2004; 63: 535-543. Go to original source... Go to PubMed...
  15. Underwood MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol 1995; 34: 1074-1077. Go to original source... Go to PubMed...
  16. Zochling J, van der Heijde D, Burgos-Vargas R et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006; 65(4): 442-52. Go to original source... Go to PubMed...
  17. Brandt J, Khariouzov A, Listing J et al. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003; 48: 1667-1675. Go to original source... Go to PubMed...
  18. Rudwaleit M, Listing J, Brandt J et al. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in AS. Ann Rheum Dis 2004; 63: 665-670. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.